What assessment finding indicates adverse effects of fludrocortisone in a patient with adrenal insufficiency?

Fludrocortisone is a mineralocorticoid agent often used in the treatment of adrenal insufficiency. One of the primary effects of fludrocortisone is the retention of sodium and water, which can lead to volume overload. Pitting edema in the feet and lower legs is a clear assessment finding that can indicate such volume overload and suggests an adverse effect due to the medication. This edema occurs as excess fluid accumulates in the tissues, resulting in swelling that leaves a temporary indentation when pressure is applied to the skin.

Monitoring for signs of fluid retention, such as pitting edema, is critical in patients receiving fludrocortisone, as it helps prevent complications related to hypertension and heart failure associated with excess sodium and water retention. Therefore, this assessment finding is significant in determining the safety and efficacy of the treatment regimen for adrenal insufficiency.

The other options do not directly correlate with the known side effects of fludrocortisone. For example, slight jaundice may indicate liver issues, while blood pressure readings within a normal range do not signify the adverse effects of the medication. Gastrointestinal symptoms, such as gas pain and belching, although potentially bothersome, are also not definitive indicators of fludrocortisone